RankAlpha logo
Back to Rankings

GANX

Gain TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
GANX vs peer average
76/100
GANX vs. peer average (B vs. D)
Grade spread
A 2 · B 1 · C 1 · D 1 · F 5
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

COYA is the first available peer comparator.

Loose small-cap biotech comparator for financing sensitivity and event-driven trading behavior; not a close operating peer to GANX's Parkinson's-focused program.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerCOYACoya Therapeutics
GANX
Gain Therapeutics
COYA
Coya Therapeutics
Grade
B
F
Momentum
82
31
Value
41
41
Sentiment
50
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs COYA

GANX / COYA
Grade Position
Above peers
GANX vs. peer average (B vs. D)
76/100
Momentum
82
GANX
Value
41
GANX
Sentiment
50
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GANX
1
COYA
COYA
F
20/100
+3
2
FATE
FATE
A
100/100
-1
3
CYPH
Cypherpunk Technologies Inc Common
C
60/100
+1
4
ATRA
Atara Biotherapeutics Inc Common
A
100/100
-1
5
ALPS
ALPS Group Inc Common
F
20/100
+3
COYA is the first peer returned for this comparison set.